SpringWorks Therapeutics | 8-K:SpringWorks Therapeutics公布2024年第三季度财务业绩和近期业务亮点
SpringWorks Therapeutics | 10-Q:2024财年三季报
SpringWorks Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Aaron I. Davis(4.6%),Boxer Capital Management, LLC(4.6%)等
SpringWorks Therapeutics | 4:持股变动声明-高管 Lin Tai-An
SpringWorks Therapeutics | 4:持股变动声明-高管 Islam Saqib
SpringWorks Therapeutics | 4:持股变动声明-高管 Edris Badreddin
SpringWorks Therapeutics | 144:拟议出售证券
SpringWorks Therapeutics | 144:拟议出售证券
SpringWorks Therapeutics | 4:持股变动声明-高管 Cassidy James
SpringWorks Therapeutics | 8-K:SpringWorks Therapeutics公布2024年第二季度财务业绩和近期业务亮点
SpringWorks Therapeutics | 10-Q:2024财年二季报
SpringWorks Therapeutics | 4:持股变动声明-董事 MACKAY MARTIN
SpringWorks Therapeutics | 3:首次持股声明-董事 MACKAY MARTIN
SpringWorks Therapeutics | 8-K:重大事件
SpringWorks Therapeutics | 4:持股变动声明-高管 Cassidy James
SpringWorks Therapeutics | 8-K:重大事件
SpringWorks Therapeutics | 4:持股变动声明-高管 Edris Badreddin
SpringWorks Therapeutics | 4:持股变动声明-董事 Hambleton Julie
SpringWorks Therapeutics | 4:持股变动声明-高管 Islam Saqib
SpringWorks Therapeutics | 144:拟议出售证券
暂无数据
暂无数据